Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Gerald, Staedtler"'
Autor:
Finn Gustafsson, Adriaan A. Voors, Gerald Staedtler, Pablo Colorado, Daniel Burkhoff, Faiez Zannad, Wilfried Dinh, James E. Udelson, Steven R. Goldsmith, Peter Kolkhof
Publikováno v:
JOURNAL OF CARDIAC FAILURE, 27(2), 233-241. Churchill Livingstone
Goldsmith, S R, Burkhoff, D, Gustafsson, F, Voors, A, Zannad, F, Kolkhof, P, Staedtler, G, Colorado, P, Dinh, W & Udelson, J E 2021, ' Dual Vasopressin Receptor Antagonism to Improve Congestion in Patients With Acute Heart Failure : Design of the AVANTI Trial ', Journal of Cardiac Failure, vol. 27, no. 2, pp. 233-241 . https://doi.org/10.1016/j.cardfail.2020.10.007
Goldsmith, S R, Burkhoff, D, Gustafsson, F, Voors, A, Zannad, F, Kolkhof, P, Staedtler, G, Colorado, P, Dinh, W & Udelson, J E 2021, ' Dual Vasopressin Receptor Antagonism to Improve Congestion in Patients With Acute Heart Failure : Design of the AVANTI Trial ', Journal of Cardiac Failure, vol. 27, no. 2, pp. 233-241 . https://doi.org/10.1016/j.cardfail.2020.10.007
BACKGROUND: Loop diuretics are the main treatment for patients with acute heart failure, but are associated with neurohormonal stimulation and worsening renal function and do not improve long-term outcomes. Antagonists to arginine vasopressin may pro
Autor:
Gerald Staedtler, Kazuma Iekushi, Thilo Krueger, Iain C. Macdougall, Tadao Akizawa, Megumi Taguchi, Jeffrey S. Berns, Thomas Bernhardt
Publikováno v:
Am J Nephrol
Background: Molidustat, a novel hypoxia-inducible factor-prolyl hydroxylase inhibitor, is being investigated for the treatment of anemia associated with chronic kidney disease (CKD). The efficacy and safety of molidustat were recently evaluated in th
Autor:
Ragna Williams, W. Wigger-Alberti, Gerald Staedtler, Yi-Ling von Mackensen, Maciej Hoffman-Wecker, Kaweh Shakery, Richard Nkulikiyinka, Ulrike Grossmann
Publikováno v:
Skin Pharmacology and Physiology. 30:102-114
Background/Aims: Psoriasis plaque tests (PPTs) are important tools in the early phases of antipsoriatic drug development. Two distinct PPT design variants (open vs. occluded drug application) are commonly used, but no previous work has aimed to direc
Autor:
Stephen, Tyring, James A, Solomon, Gerald, Staedtler, Jason P, Lott, Richard, Nkulikiyinka, Kaweh, Shakery
Publikováno v:
Cutis. 98(4)
Patient-reported treatment outcomes are important for evaluating the impact of drug therapies on patient experience. A randomized, double-blind, vehicle-controlled, parallel-group, multicenter, phase 3 study was conducted in 961 participants to asses
Autor:
James A, Solomon, Stephen, Tyring, Gerald, Staedtler, Meike, Sand, Richard, Nkulikiyinka, Kaweh, Shakery
Publikováno v:
Cutis. 98(3)
Papulopustular rosacea (PPR) is characterized by centrofacial papules and pustules commonly associated with erythema. To compare investigator-reported efficacy outcomes for azelaic acid (AzA) foam 15% versus vehicle foam in PPR, a randomized, vehicle
Autor:
Zoe Diana, Draelos, Boni E, Elewski, Julie C, Harper, Meike, Sand, Gerald, Staedtler, Richard, Nkulikiyinka, Kaweh, Shakery
Publikováno v:
Cutis. 96(1)
Rosacea is a chronic relapsing skin disorder primarily affecting the face. Although its etiology is not well defined, rosacea is associated with immune dysregulation and inflammation potentiated by external factors. These manifestations lead to skin
Publikováno v:
Cutis. 92(6)
Rosacea is a common chronic inflammatory skin disease that primarily affects facial skin. Its etiology is unknown, and currently there is no cure. Rosacea can be associated with severe symptoms, including transient erythema (flushing), nontransient e
Publikováno v:
Journal of drugs in dermatology : JDD. 9(6)
Rosacea is a leading reason why people seek the care of a dermatologist, accounting for nearly 7 million office visits annually. Pharmacologic treatments include both topical and oral medications, which are increasingly being used in combination, esp